SCHEMBL25087362

SCHEMBL25087362

O=C(OCc1ccccc1)c1ccc(Br)cc1C(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TDP1 Q9NUW8 4/20 0.49
KMT2A Q03164 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
TSHR P16473 2/20 0.46
CYP3A4 P08684 1/20 0.44
MAPK1 P28482 1/20 0.44
LMNA P02545 3/20 0.43
POLB P06746 1/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EGLN1 Q9GZT9 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HPGD P15428 1/20 0.41
PTGES O14684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644360 0.85 ALDH1A1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL18703864 0.81 ALDH1A1 (0.57) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL23457841 0.80 TDP1 (0.67) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL3950165 0.79 ALDH1A1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL31737536 0.79 ALDH1A1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL31006678 0.79 ALDH1A1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL19479103 0.79 ALDH1A1 (0.54) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL7553264 0.78 ALDH1A1 (0.50) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL25087359 0.78 ALDH1A1 (0.53) ALDH1A1TDP1KMT2ASLC6A2SLC6A3
SCHEMBL30207843 0.78 HTT (0.53) ALDH1A1TDP1KMT2ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023027948-A1 JAK2 INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed